User profiles for Abhinaya Ganesan

Abhinaya Ganesan

Baylor College of medicine
Verified email at bcm.edu
Cited by 202

[HTML][HTML] Durable SARS-CoV-2 B cell immunity after mild or severe disease

…, HS Park, K Littlefield, A Ganesan… - The Journal of …, 2021 - Am Soc Clin Investig
Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific
(SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral …

Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection

…, K Littlefield, HS Park, RL Ursin, A Ganesan… - American journal of …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2, the disease-causing
pathogen of the coronavirus disease 2019 pandemic, has resulted in morbidity and mortality …

Dysregulated immunity in SARS-CoV-2 infected pregnant women

…, S Olson, K Littlefield, HS Park, RL Ursin, A Ganesan… - medRxiv, 2020 - medrxiv.org
Importance The effects of SARS-CoV-2 infection on immune responses during pregnancy
have not been systematically evaluated. Objective To assess the impact of SARS-CoV-2 …

[HTML][HTML] Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children

…, S Yoon, D Jung, K Littlefield, A Ganesan… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND While most children who contract COVID-19 experience mild disease, high-risk
children with underlying conditions may develop severe disease, requiring interventions…

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in a longitudinally sampled …

…, HS Park, RL Ursin, A Ganesan… - Open Forum …, 2021 - academic.oup.com
Background Sustained molecular detection of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) RNA in the upper respiratory tract (URT) in mild to moderate coronavirus …

[HTML][HTML] Application of machine learning models to identify serological predictors of COVID-19 severity and outcomes

…, HS Park, M Parish, C Caputo, A Ganesan… - Research …, 2023 - ncbi.nlm.nih.gov
Critically ill people with COVID-19 have greater antibody titers than those with mild to
moderate illness, but their association with recovery or death from COVID-19 has not been …

Characterization of Cu-only SOD repeat protein in Zebrafish (Danio rerio)

A Ganesan - 2020 - jscholarship.library.jhu.edu
Superoxide dismutase (SOD) are enzymes that catalyze the dismutation of superoxide
radicals into oxygen and hydrogen peroxide using redox active metals such as copper. These …

Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer

…, P Gong, JD Landua, RR Srinivasan, A Ganesan… - bioRxiv, 2023 - biorxiv.org
Tumor-initiating cells (TIC) are a tumor cell subpopulation thought to be responsible for
therapeutic resistance and metastasis. Using a Signal Transducer and Activator of Transcription (…

Sex hormones more than sex chromosomal complement predict sex differences in influenza vaccine-induced immunity and protection in mice

K Seddu, S Dhakal, A Ganesan… - The Journal of …, 2022 - journals.aai.org
Following influenza vaccination, adult female mice have greater quantity and quality of
antiviral antibodies than males, which is a correlate of protection against live influenza virus …

Abstract PO5-24-02: Interferon-induced bone marrow stromal antigen 2 (BST2) is a functional tumor-initiating cell marker in triple-negative breast cancer

…, J Landua, R Srinivasan, L Dobrolecki, A Ganesan… - Cancer Research, 2024 - AACR
Background: A subpopulation of tumor cells known to have intrinsic resistance to therapies
and contribute to metastasis function as “cancer stem”, or tumor-initiating, cells (TICs). TICs …